NL10

Size: px
Start display at page:

Download "NL10"

Transcription

1 Information September,

2 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

3 September,

4 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

5 September,

6 6 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

7 β September,

8 8 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

9 September,

10 10 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

11 β September,

12 12 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

13 κ κ β κ September,

14 κ 14 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

15 September,

16 β β 16 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

17 α September,

18 Special Lecture The NCI 60 Human Tumor Cell Line Anticancer Drug Screen: An information-rich Screen Complementary to Molecular-Targeted Screens 18 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

19 Symposium September,

20 20 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

21 September,

22 MiniSymposium 1 I 22 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

23 September,

24 MiniSymposium 2 II 24 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

25 κ September,

26 26 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

27 Session 1 September,

28 α β 28 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

29 Session 2 β β β β β September,

30 30 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

31 Session 3 γ September,

32 32 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

33 Session 4 September,

34 α 34 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

35 α September,

36 Session 5 κ κ κκ κ 36 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

37 κ κ κ September,

38 Session 6 38 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

39 September,

40 Session 7 40 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

41 September,

42 Poster Session κ κ κ κ 42 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

43 Poster Session β κ κ κ κ β September,

44 Poster Session α α 44 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

45 September,

46 Poster Session β β γ 46 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

47 Poster Session κ September,

48 Poster Session β β β φ) β φ φ βφ µ γ 48 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

49 Poster Session September,

50 Poster Session 50 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

51 September,

52 Poster Session 52 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

53 Poster Session September,

54 Poster Session β β 54 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

55 Poster Session β α September,

56 56 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

57 September,

58 58 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

59 September,

60 60 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10

61

62

63

64

NL09

NL09 Information September, 2005 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.9 September, 2005 3 2005 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

More information

第86回日本感染症学会総会学術集会後抄録(I)

第86回日本感染症学会総会学術集会後抄録(I) κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β

More information

研修コーナー

研修コーナー l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l

More information

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35

More information

1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915

More information

nsg02-13/ky045059301600033210

nsg02-13/ky045059301600033210 φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W

More information

untitled

untitled Japanese Standards Association 2014 http://www.jsa.or.jp/kentei/qc/qc-top.asp

More information

<4F495341836A8385815B835832308EFC944E8B4C944F8D862E696E6464>

<4F495341836A8385815B835832308EFC944E8B4C944F8D862E696E6464> OITA INFORMATION SERVICE INDUSTRY ASSOCIATION CONTENTS 2009. 3 47 02 OITA INFORMATION SERVICE INDUSTRY ASSOCIATION NEWS 03 OITA INFORMATION SERVICE INDUSTRY ASSOCIATION 04 05 NEWS OITA INFORMATION SERVICE

More information

nsg04-28/ky208684356100043077

nsg04-28/ky208684356100043077 δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!

More information

n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m

n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m 1 1 1 + 1 4 + + 1 n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m a n < ε 1 1. ε = 10 1 N m, n N a m a n < ε = 10 1 N

More information

SPP24_Program_WOC(J)-15

SPP24_Program_WOC(J)-15 9:00-9:10 9:20-10:00 Invited Lecture A1-01-I 1 10:00-10:20 A1-02 3 10:20-10:40 A1-03 5 9:20-9:40 B1-01 7 9:40-10:00 B1-02 9 10:00-10:20 B1-03 11 10:20-10:40 B1-04 13 - i - 11:00-12:00 Plenary Lecture S-01

More information